Skip to main content

Corbus Pharmaceuticals Holdings, Inc.

CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595097

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CRBP: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders107399−5
Shares11.8M176.1K11.0M−633.3K (−5.5%)
Value$243.1M$4.03M$129.3M−$109.8M (−45.9%)

3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (21)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CRBP in Q4 2024
InstitutionSharesValue% of portfolio
Armistice Capital, LLC236,000$2.78M0.06%
Gsa Capital Partners LLP36,647$432.0K0.03%
Jump Financial, LLC28,709$338.8K0.01%
BNP Paribas Arbitrage, SA27,383$323.1K0.00%
Jain Global LLC15,426$182.0K0.01%
Two Sigma Advisers, LP11,027$130.1K0.00%
Aquatic Capital Management LLC8,555$100.9K0.00%
Group One Trading, L.P.8,158$96.3K0.00%
Avanza Fonder AB7,150$84.4K0.00%
Police & Firemen's Retirement System of New Jersey2,043$24.1K0.00%
Simplex Trading, LLC899$10.0K0.00%
R Squared Ltd760$8.97K0.01%
MAI Capital Management185$2.18K0.00%
SBI Securities Co., Ltd.103$1.22K0.00%
Golden State Wealth Management, LLC73$8610.00%
Caitong International Asset Management Co., Ltd73$8610.00%
Spire Wealth Management66$7790.00%
Curio Wealth, LLC23$2710.00%
Vision Financial Markets LLC14$1650.00%
IFP Advisors, Inc1$120.00%
EverSource Wealth Advisors, LLC1$120.00%

Sold out (26)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (3)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRBP in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Ghost Tree Capital, LLC160,000$3.30M
ClariVest Asset Management LLC16,021$725.0K
Carmichael Hill & Associates, Inc.100$2.06K